glp-1 diapason Therapeutic Potential of Receptor Agonists in Diabetes and Cardiovascular Disease: Mechanisms and Clinical Implications | Cardiovascular Drugs and Therapy Targeting GLP-1, GIP & GCG

Interested in gut peptides, in 1980 Lund found a gene for the glucagon precursor in Goodman's library (Lund, Goodman, Dee, Habenerr)

They cost $119 for the first month and $199 per month after

administration of the experimental compounds (MK-801, GLP-1, GLP-1MK-801 (all at doses of 100 nmol kg 1 ), semaglutide (10 nmol kg 1 ) or isotonic saline as vehicle)

It stopped working

Injectables may remain preferred for patients needing maximum weight reduction

Quick Answer: Weight loss injections may not work due to insufficient treatment duration, inadequate dosing, underlying medical conditions, compensatory eating behaviors, improper injection technique, or individual metabolic variation in drug response